PD-L1 POSITIVE

Clinical trials for PD-L1 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new PD-L1 POSITIVE trials appear

Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2

Promising combo may keep rare melanoma at bay

Disease control Recruiting now

This study tests whether adding the immunotherapy drug sintilimab to standard chemotherapy can help prevent a rare type of skin cancer (mucosal melanoma) from coming back after surgery. About 220 adults with PD-L1-positive, completely removed tumors will be randomly assigned to g…

Matched conditions: PD-L1 POSITIVE

Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

PD-L1 POSITIVE

Get alerted when new PD-L1 POSITIVE trials appear

Promising combo may keep rare melanoma at bay